ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 32951 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 32951; 2) Community: the network communities that were significantly associated with the response to NSC 32951; 3) Molecule: the relationships between components within communities and NSC 32951; 4) MDR: the compounds that were significantly associated with the NSC 32951.

NSC Compound Enrichment Correlation
NSC 175630 Toyocamycin, 6-amino- 0.049093561024907 0.39144934
NSC 237677 Null 0.049093561024907 0.62172653
NSC 296301 Null 0.049093561024907 0.23105309
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.049093561024907 -0.04784029
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.049093561024907 0.06694346
NSC 113943 6-Bromosangivamycin 1.37775076606011e-005 0.37047525
NSC 682840 Butanimidoyl chloride, N-[[[[4-(trifluoromethoxy)phenyl] amino]carbonyl]oxy]- 2.16417361041569e-005 0.47373434
NSC 682838 Propanimidoyl chloride, N-[[[(5-chloro-2-methoxyphenyl) amino]carbonyl]oxy]-2-methyl- 2.45480643638598e-005 0.47192332
Total:71  Current:71    [First] [Prev] [Next] [Last]